Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfen Liu

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Journal of Cancer|January 17, 2024
Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer AnalysisYanfen Liu, Lu Wei, Zhiyu Zhu, et al.
Chemosphere|December 5, 2021
Effects of perfluoroalkyl substances on root and rhizosphere bacteria: Phytotoxicity, phyto-microbial remediation, risk assessmentHuinian Liu, Wenli Hu, Xin Li, et al.
Frontiers in Immunology|January 23, 2025
Pseudoprogression in CAR-T cell therapy for solid tumor: Case reportXuan Zhao, Yanfen Liu, Guohui Qin, et al.
Angewandte Chemie (International Ed. in English)|January 29, 2025
Targeted Docking of Localized Hydrogen Bond for Efficient and Reversible Zinc-Ion BatteriesPinji Wang, Tian Chen Li, Yanfen Liu, et al.
Frontiers in Molecular Biosciences|April 4, 2022
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network PharmacologyLili Yan, Zhen Zhang, Yanfen Liu, et al.
Plos One|December 3, 2010
The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory groupQiuyan Wang, Bidhan A Shinkre, Jin-gu Lee, et al.
Cell Death & Disease|October 23, 2020
ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinomaZhuoyu Gu, Liping Wang, Xiaohan Yao, et al.
Experimental and Therapeutic Medicine|October 19, 2017
Elevation of <i>PTPN1</i> promoter methylation is a significant risk factor of type 2 diabetes in the Chinese populationQing Huang, Liyuan Han, Yanfen Liu, et al.
Stroke|September 2, 2025
MFN2 and BAG6 Synergistically Protect Against Cerebral Reperfusion Injury by Regulating ROS Levels and Autophagic FluxDongting Lu, Yukun Yang, Guodong Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2026
Linear ubiquitination of the NMDA receptor GluN2A subunit facilitates the GluN2B-to-GluN2A switch and synaptic maturationYuanyuan Chu, Yiwen Xu, Maoqing Huang, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Cancer|January 17, 2024
Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer AnalysisYanfen Liu, Lu Wei, Zhiyu Zhu, et al.
Chemosphere|December 5, 2021
Effects of perfluoroalkyl substances on root and rhizosphere bacteria: Phytotoxicity, phyto-microbial remediation, risk assessmentHuinian Liu, Wenli Hu, Xin Li, et al.
Frontiers in Immunology|January 23, 2025
Pseudoprogression in CAR-T cell therapy for solid tumor: Case reportXuan Zhao, Yanfen Liu, Guohui Qin, et al.
Angewandte Chemie (International Ed. in English)|January 29, 2025
Targeted Docking of Localized Hydrogen Bond for Efficient and Reversible Zinc-Ion BatteriesPinji Wang, Tian Chen Li, Yanfen Liu, et al.
Frontiers in Molecular Biosciences|April 4, 2022
Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network PharmacologyLili Yan, Zhen Zhang, Yanfen Liu, et al.
Plos One|December 3, 2010
The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory groupQiuyan Wang, Bidhan A Shinkre, Jin-gu Lee, et al.
Cell Death & Disease|October 23, 2020
ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinomaZhuoyu Gu, Liping Wang, Xiaohan Yao, et al.
Experimental and Therapeutic Medicine|October 19, 2017
Elevation of <i>PTPN1</i> promoter methylation is a significant risk factor of type 2 diabetes in the Chinese populationQing Huang, Liyuan Han, Yanfen Liu, et al.
Stroke|September 2, 2025
MFN2 and BAG6 Synergistically Protect Against Cerebral Reperfusion Injury by Regulating ROS Levels and Autophagic FluxDongting Lu, Yukun Yang, Guodong Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2026
Linear ubiquitination of the NMDA receptor GluN2A subunit facilitates the GluN2B-to-GluN2A switch and synaptic maturationYuanyuan Chu, Yiwen Xu, Maoqing Huang, et al.
Pageof 10